MAGNETOM World

Clinical Talks

Experience the talks we have captured during various Workshops and Events.

Preview Clinical Talk Adrienne Campbell-Washburn

The Role of Artificial Intelligence in Improving MR Sequences for Female Pelvis Applications

2025-07-02

Isabelle Thomassin-Naggara, M.D., Ph.D. (Sorbonne Université, Paris, France)

Improved Cardiac Diffusion Tensor Metrics with Ultra High-Performance Gradients “made easy”

2025-06-25

Christopher Nguyen, Ph.D., FSCMR, AACC

(Cleveland Clinic, Cardiovascular Innovation Research Center, Cleveland, OH, USA)

NextGen PET/MR in Practice: First Experiences from BIOGRAPH One

2025-06-24

Thomas Lund Andersen, Ph.D.
(Rigshospitalet, Copenhagen, Denmark)

ISMRM Lunch Symposium, Hawaii, 2025

Low Field CMR. Bridging Gaps in Healthcare Accessibility

2025-05-07

Orlando P. Simonetti, Ph.D. (The Ohio State University, Columbus, OH, USA)

Siemens Healthineers Lunch Symposium, SMRA 2024

Real-life experience using a fully automated CMR planning software in a Swiss radiology department

2025-02-18

Carl Glessgen, M.D. (Geneva University Hospitals, Switzerland)

Siemens Healtineers Lunch Symposium SCMR 2025, Washington, DC, USA

ARIA Imaging and Workflows

2025-02-13

Petrice Cogswell, M.D., Ph.D.

(Mayo Clinic, Rochester, MN, USA)

Siemens Healthineers Symposium RSNA 2024

Advancing Diffusion MRI for Comprehensive Characterisation of the Prostate Gland

2024-10-16

Malwina Molendowska, Ph.D. (CUBRIC, Cardiff, UK / Lund University, Sweden)
Siemens Healthineers Lunch Symposium, ESMRMB 2023, Basel, Switzerland

Strategies to Reduce Sedation in Pediatric MRI Exams

2024-07-09

Camilo Jaimes, M.D. (Massachusetts General Hospital, Boston, MA, USA)
ESPR 2024, Sevilla, Spain

3D Whole Heart Imaging in Cardiovascular MRI. Exploring the Range of Clinical Applications

2024-03-12

Evangelia Nyktari, M.D. (Cardiovascular MRI Unit, Onassis Cardiac Surgery Center, Athens, Greece)

Next Generation 3D Whole Heart CMR with 100% Respiratory Efficiency: The Power of Collaboration

2024-03-12

René M. Botnar, Ph.D. (School of Biomedical Engineering and Imaging Sciences, King’s College London / Institute of Biological and Medical Engineering, Pontificia Universidad Católica de Chile)

Exploring the Potential of 0.55T MRI: Triumphs, Trials, and Future Horizons

2024-03-12

Michael Bach, M.D. (University Hospital Basel, Switzerland)
Siemens Healthineers Lunch Symposium, ESMRMB 2023, Basel, Switzerland

CMR MasterClass: Common CMR Cases

2023-11-09

Chiara Bucciarelli-Ducci, MD, PhD, FESC, FRCP, AFCC, FSCMR, FEACVI (Royal Brompton and Harefield Hospitals, London, UK)

How is 7T MRI changing the game in epilepsy

2023-09-08

Maxim Guye, MD, PhD (Centre for MR in Biology and Medicine, Aix-Marseille University & University Hospital, Marseille, France)

How high-performance gradients provide new insights into neurological disease

2023-09-08

Susie Y. Huang, MD, PhD (Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Boston, MA, USA)

Accelerated, High-Resolution TSE Deep Learning Reconstructions for Pediatric MSK MRI

2023-07-21

Sarah Bixby, M.D., MBA (Boston Children’s Hospital; Harvard Medical School, Boston, MA, USA)

SPR Lunch Symposium 2023

The herein illustrated statements made by Siemens’ customers and physicians are based on their own and discrete opinion. The speaker is responsible for obtaining permission to use any previously published figures or tables. The speaker is also responsible for obtaining permission to reproduce any photograph showing recognizable persons.

The statements by Siemens’ customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" setting and many variables exist there can be no guarantee that other customers will achieve the same results.

Some products/features (here mentioned) are not necessarily commercially available in all countries. Due to regulatory reasons their availability cannot be guaranteed. Please contact your local Siemens organization for further details.

MAGNETOM 7T and 9.4T are ongoing research. All data shown are acquired using non-commercial systems under institutional review board permission. Siemens does not intend to commercialize the systems. MAGNETOM Terra is currently under development and is not for sale in the US and in other countries. Its future availability cannot be ensured.

The MRI restrictions (if any) of the metal implant must be considered prior to patient undergoing MRI exam. MR imaging of patients with metallic implants brings specific risks. However, certain implants are approved by the governing regulatory bodies to be MR conditionally safe. For such implants, the previously mentioned warning may not be applicable. Please contact the implant manufacturer for the specific conditional information. The conditions for MR safety are the responsibility of the implant manufacturer, not of Siemens.

MR scanning has not been established as safe for imaging fetuses and infants less than two years of age. The responsible physician must evaluate the benefits of the MR examination compared to those of other imaging procedures.